Variables | Number (percent) |
---|---|
Age§ | 46.0 years (15–75) |
< 55 years | 822 (76.0) |
≥ 55 years | 260 (24.0) |
Sex | |
Female | 869 (80.3) |
Male | 213 (19.7) |
Underlying disease | |
Hypertension | 183 (16.9) |
Diabetes | 71 (6.6) |
Tumor size* | 1.15 cm ± 0.74 |
≤ 1 cm | 652 (60.3) |
> 1 cm | 430 (39.7) |
T stage | |
T1a | 622 (57.5) |
T1b | 230 (21.3) |
T2 | 51 (4.7) |
T3a | 3 (0.3) |
T3b | 119 (11.0) |
T4a | 57 (5.3) |
Number of harvested lymph node | |
≤ 4 | 447 (41.3) |
≥ 5 | 635 (58.7) |
Multifocality | 331 (30.6) |
Bilaterality | 242 (22.4) |
Chronic lymphocytic thyroiditis | 334 (30.9) |
Lymphovascular invasion | 23 (2.1) |
TNM stage | |
Stage I | 950 (87.8) |
Stage II | 116 (10.7) |
Stage III | 16 (1.5) |
Radioactive iodine therapy | 986 (91.1) |
Recurrence | 62 (5.7) |
follow-up§ | 78 months (12–158) |
Total patients | 1082 (100) |